NASDAQ : GYRE
Gyre Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.41 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 679.68M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Gyre Therapeutics, Inc. (GYRE) reported revenue of 109.82M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 109.82M | 116.59M | 105.76M | 113.45M | 102.29M |
| Cost of Revenue | 6.81M | 5.42M | 3.88M | 4.64M | 4.79M |
| Gross Profit | 103.01M | 111.17M | 101.87M | 108.81M | 97.50M |
| Selling, General & Admin | 90.40M | 85.98M | 73.62M | 75.82M | 71.61M |
| Research & Development | 27.87M | 13.70M | 12.02M | 13.78M | 16.69M |
| Operating Expenses | 118.27M | 99.68M | 85.64M | 89.60M | 88.29M |
| Operating Income | -15.26M | 11.49M | 16.23M | 19.21M | 9.20M |
| Interest & Investment Income | 1.43M | 1.75M | 1.55M | 1.04M | 726.00K |
| Earnings From Equity Investments | -82.00K | -77.00K | -37.00K | -1.31M | -251.00K |
| Currency Exchange Gain (Loss) | -1.50M | -4.90M | |||
| Other Non Operating Income (Expenses) | -2.29M | 479.00K | 5.45M | -8.96M | 3.73M |
| EBT Excluding Unusual Items | -16.20M | 13.64M | 23.18M | 8.48M | 8.51M |
| Gain (Loss) on Sale of Assets | -4.00K | -4.00K | -66.00K | -3.34M | |
| Other Unusual Items | 800.00K | 800.00K | 100.00K | 1.00M | 900.00K |
| Pretax Income | -22.29M | 14.44M | 23.22M | -76.97M | 9.41M |
| Income Tax Expense | 3.38M | 4.56M | 5.32M | 8.52M | 5.10M |
| Earnings From Continuing Operations | -25.67M | 9.88M | 17.90M | -85.48M | 4.31M |
| Minority Interest in Earnings | 4.45M | -4.85M | -5.81M | -7.45M | -2.01M |
| Net Income | -21.22M | 5.03M | 12.09M | -92.93M | 2.30M |
| Net Income to Common | -19.91M | 5.03M | 12.09M | -92.93M | 2.30M |
| Shares Outstanding (Basic) | 93.70M | 89.34M | 85.09M | 65.83M | 63.59M |
| Shares Outstanding (Diluted) | 93.70M | 103.18M | 102.29M | 65.83M | 75.69M |
| EPS (Basic) | -0.21 | 0.06 | 0.14 | -1.41 | 0.04 |
| EPS (Diluted) | -0.22 | 0.02 | 0.05 | -1.41 | 0.03 |
| Free Cash Flow | -6.11M | -180.00K | -5.96M | 17.38M | 5.69M |
| Free Cash Flow Per Share | -0.07 | -0.00 | -0.06 | 0.26 | 0.07 |
| Gross Margin | 93.80% | 95.36% | 96.33% | 95.91% | 95.31% |
| Operating Margin | -13.90% | 9.86% | 15.35% | 16.93% | 9.00% |
| Profit Margin | -18.13% | 4.31% | 11.43% | -81.92% | 2.25% |
| Free Cash Flow Margin | -5.56% | -0.15% | -5.63% | 15.32% | 5.56% |
| EBITDA | -12.13M | 14.01M | 17.82M | 20.33M | 10.33M |
| EBITDA Margin | -11.05% | 12.02% | 16.85% | 17.92% | 10.10% |
| D&A For EBITDA | 3.13M | 2.52M | 1.59M | 1.11M | 1.13M |
| EBIT | -15.26M | 11.49M | 16.23M | 19.21M | 9.20M |
| EBIT Margin | -13.90% | 9.86% | 15.35% | 16.93% | 9.00% |
| Effective Tax Rate | 31.56% | 22.91% | 54.16% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 43.29M | 37.07M | 11.81M | 33.51M | 25.18M |
| Short-Term Investments | 31.51M | 15.36M | 14.86M | ||
| Cash & Short-Term Investments | 74.80M | 52.42M | 26.67M | 33.51M | 25.18M |
| Accounts Receivable | 27.76M | 31.08M | 19.59M | 15.16M | 15.61M |
| Other Receivables | 255.00K | 230.00K | 5.19M | 1.29M | |
| Receivables | 28.25M | 36.95M | 29.15M | 16.84M | 17.14M |
| Inventory | 11.43M | 10.17M | 6.34M | 4.28M | 6.12M |
| Prepaid Expenses | 7.60M | 1.34M | 1.19M | 1.55M | 377.00K |
| Other Current Assets | 1.49M | 1.44M | 1.04M | 843.00K | |
| Total Current Assets | 122.07M | 102.37M | 64.79M | 57.22M | 49.65M |
| Property, Plant & Equipment | 30.56M | 24.73M | 25.70M | 23.78M | 18.38M |
| Long-Term Investments | 30.24M | 25.12M | 26.17M | 23.43M | 7.39M |
| Other Intangible Assets | 4.53M | 6.15M | 1.71M | 1.70M | 1.86M |
| Long-Term Deferred Tax Assets | 9.28M | 6.87M | 5.62M | 4.70M | 4.08M |
| Other Long-Term Assets | 2.57M | 892.00K | 1.43M | 5.72M | 3.39M |
| Total Assets | 199.25M | 166.13M | 125.41M | 116.54M | 84.75M |
| Accounts Payable | 1.24M | 124.00K | 108.00K | 355.00K | 122.00K |
| Accrued Expenses | 16.08M | 12.09M | 9.30M | 10.56M | 6.77M |
| Current Portion of Leases | 1.39M | 636.00K | 713.00K | 210.00K | 492.00K |
| Current Income Taxes Payable | 2.15M | 2.94M | 2.83M | 5.05M | 2.10M |
| Current Unearned Revenue | 213.00K | 111.00K | 156.00K | 79.00K | 167.00K |
| Other Current Liabilities | 7.60M | 2.39M | 6.41M | 3.79M | 2.59M |
| Total Current Liabilities | 28.66M | 18.29M | 19.52M | 20.05M | 12.24M |
| Long-Term Leases | 2.03M | 303.00K | 885.00K | 199.00K | 121.00K |
| Long-Term Unearned Revenue | 829.00K | 852.00K | 928.00K | 213.00K | 118.00K |
| Other Long-Term Liabilities | 2.81M | 4.41M | 5.67M | 17.61M | 55.00K |
| Total Liabilities | 34.34M | 23.85M | 27.00M | 38.06M | 12.54M |
| Common Stock | 106.00K | 91.00K | 86.00K | 77.00K | 64.00K |
| Additional Paid-In Capital | 240.64M | 172.05M | 136.19M | 68.18M | 32.80M |
| Retained Earnings | -134.31M | -65.33M | -70.36M | -82.44M | 10.05M |
| Comprehensive Income & Other | 1.49M | -779.00K | -2.60M | -1.64M | -392.00K |
| Total Common Equity | 107.93M | 106.03M | 63.32M | -15.83M | 42.52M |
| Minority Interest | 34.56M | 36.25M | 35.08M | 29.78M | 29.70M |
| Shareholders' Equity | 164.92M | 142.28M | 98.40M | 78.47M | 72.22M |
| Total Liabilities & Equity | 199.25M | 166.13M | 125.41M | 116.54M | 84.75M |
| Total Debt | 3.42M | 939.00K | 1.60M | 409.00K | 613.00K |
| Net Cash (Debt) | 71.38M | 51.49M | 25.07M | 33.10M | 24.56M |
| Net Cash Per Share | 0.76 | 0.50 | 0.25 | 0.50 | 0.32 |
| Filing Date Shares Outstanding | 106.03M | 91.31M | 93.61M | 85.42M | 63.59M |
| Total Common Shares Outstanding | 106.03M | 91.31M | 86.31M | 76.60M | 63.59M |
| Working Capital | 93.41M | 84.08M | 45.27M | 37.17M | 37.41M |
| Book Value Per Share | 1.02 | 1.16 | 0.73 | -0.21 | 0.67 |
| Tangible Book Value | 103.40M | 99.88M | 61.61M | -17.53M | 40.67M |
| Tangible Book Value Per Share | 0.98 | 1.09 | 0.71 | -0.23 | 0.64 |
| Buildings | 20.30M | 19.57M | 18.98M | 12.29M | 10.84M |
| Machinery | 16.77M | 10.84M | 10.28M | 7.39M | 5.68M |
| Construction In Progress | 566.00K | 765.00K | 222.00K | 7.88M | 4.85M |
| Leasehold Improvements | 2.35M | 334.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -21.22M | 5.03M | 12.09M | -92.93M | 2.30M |
| Depreciation & Amortization | 3.13M | 2.52M | 1.59M | 1.11M | 1.13M |
| Loss (Gain) From Sale of Assets | 21.00K | 4.00K | 66.00K | 3.34M | 4.00K |
| Asset Writedown & Restructuring Costs | 83.10M | ||||
| Loss (Gain) on Equity Investments | 82.00K | 77.00K | 37.00K | 1.31M | 251.00K |
| Stock-Based Compensation | 9.87M | 7.16M | 831.00K | 7.28M | 13.37M |
| Provision & Write-off of Bad Debts | 72.00K | -63.00K | 170.00K | -61.00K | 22.00K |
| Other Operating Activities | -6.85M | 4.55M | 4.44M | 6.01M | 1.40M |
| Change in Accounts Receivable | -1.74M | -10.81M | -5.26M | 285.00K | -7.92M |
| Change in Inventory | -2.06M | -3.63M | -2.14M | 1.75M | -879.00K |
| Change in Accounts Payable | -551.00K | 13.00K | -245.00K | 192.00K | -112.00K |
| Change in Income Taxes | 920.00K | 44.00K | -2.17M | 3.00M | -1.34M |
| Change in Other Net Operating Assets | 5.19M | -3.88M | -13.05M | 11.49M | 2.46M |
| Operating Cash Flow | -4.93M | 1.01M | -3.64M | 25.89M | 10.68M |
| Capital Expenditures | -1.17M | -1.19M | -2.31M | -8.52M | -4.99M |
| Sale of Property, Plant & Equipment | 24.00K | 30.00K | 401.00K | 664.00K | |
| Cash Acquisitions | 5.46M | ||||
| Divestitures | -566.00K | ||||
| Sale (Purchase) of Intangibles | -1.04M | -733.00K | -813.00K | -69.00K | -13.00K |
| Investment in Securities | 5.10M | 1.42M | -17.16M | -16.73M | -8.82M |
| Investing Cash Flow | 2.91M | -474.00K | -19.88M | -19.76M | -13.81M |
| Issuance of Common Stock | 589.00K | 25.86M | 2.64M | ||
| Other Financing Activities | 2.21M | -1.49M | -536.00K | ||
| Financing Cash Flow | 2.80M | 24.38M | 2.10M | 2.50M | |
| Foreign Exchange Rate Adjustments | 1.26M | 343.00K | -273.00K | -298.00K | -1.89M |
| Net Cash Flow | 2.04M | 25.26M | -21.70M | 8.33M | -5.03M |
| Free Cash Flow | -6.11M | -180.00K | -5.96M | 17.38M | 5.69M |
| Free Cash Flow Margin | -5.56% | -0.15% | -5.63% | 15.32% | 5.56% |
| Free Cash Flow Per Share | -0.07 | -0.00 | -0.06 | 0.26 | 0.07 |
| Levered Free Cash Flow | 1.88M | 1.95M | -6.00M | 20.67M | |
| Unlevered Free Cash Flow | 1.88M | 1.95M | -6.00M | 20.67M | |
| Cash Income Tax Paid | 5.62M | 5.62M | 8.52M | 6.35M | 6.31M |
| Change in Working Capital | 9.96M | -18.26M | -22.86M | 16.72M | -7.80M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 501.54M | 641.69M | 1.04B | 1.97B | |
| Enterprise Value | 430.16M | 618.30M | 1.05B | 1.95B | |
| Last Close Price | 4.73 | 7.06 | 12.10 | 25.69 | |
| PE Ratio | 127.65 | 85.93 | |||
| Forward PE | 32.84 | ||||
| PS Ratio | 4.57 | 5.50 | 9.82 | 17.34 | |
| PB Ratio | 4.65 | 4.51 | 10.55 | 25.07 | |
| P/TBV Ratio | 4.85 | 6.42 | 16.85 | ||
| P/FCF Ratio | 113.23 | ||||
| P/OCF Ratio | 635.33 | 75.99 | |||
| EV/Sales Ratio | 3.92 | 5.30 | 9.93 | 17.15 | |
| EV/EBITDA Ratio | 44.13 | 58.96 | 95.72 | ||
| EV/EBIT Ratio | 53.81 | 64.73 | 101.27 | ||
| EV/FCF Ratio | 111.98 | ||||
| Debt / Equity Ratio | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 |
| Debt / EBITDA Ratio | 0.06 | 0.09 | 0.02 | 0.06 | |
| Debt / FCF Ratio | 0.02 | 0.11 | |||
| Net Debt / Equity Ratio | -0.43 | -0.36 | -0.26 | -0.42 | -0.34 |
| Net Debt / EBITDA Ratio | 5.88 | -3.67 | -1.41 | -1.63 | -2.38 |
| Net Debt / FCF Ratio | 11.69 | 286.03 | 4.21 | -1.91 | -4.32 |
| Asset Turnover | 0.62 | 0.80 | 0.87 | 1.13 | |
| Inventory Turnover | 0.67 | 0.66 | 0.73 | 0.89 | |
| Quick Ratio | 3.59 | 4.58 | 2.64 | 2.49 | 3.33 |
| Current Ratio | 4.26 | 5.60 | 3.32 | 2.85 | 4.06 |
| Return on Equity (ROE) | -17.44% | 8.21% | 20.24% | -113.45% | |
| Return on Assets (ROA) | -5.42% | 4.93% | 8.38% | 11.93% | |
| Return on Invested Capital (ROIC) | -16.81% | 9.58% | 21.08% | 41.30% | 8.85% |
| Return on Capital Employed (ROCE) | -8.90% | 7.80% | 15.30% | 19.90% | 12.70% |
| Earnings Yield | -4.58% | 0.78% | 1.16% | -4.72% | |
| FCF Yield | -1.22% | -0.03% | -0.57% | 0.88% | |
| Buyback Yield / Dilution | 1.16% | -0.87% | -55.39% | 13.02% |